Hedge Fund - OrbiMed Advisors

Biogen Inc. (BIIB) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2023 - Q4 (2023-12-31) $214,158,052 4.27% 827,600 $245.62
2 2023 - Q3 (2023-09-30) $143,103,168 3.03% 556,800 $267.47
3 2023 - Q2 (2023-06-30) $158,604,480 2.87% 556,800 $297.84
4 2023 - Q1 (2023-03-31) $140,405,150 2.75% 505,000 $276.70
5 2022 - Q4 (2022-12-31) $71,500,744 1.36% 258,200 $282.44
6 2022 - Q3 (2022-09-30) $59,968,000 1.11% 224,600 $212.38
7 2022 - Q2 (2022-06-30) $22,760,000 0.41% 111,600 $204.43
8 2022 - Q1 (2022-03-31) $24,830,000 0.4% 117,900 $217.46
9 2021 - Q4 (2021-12-31) $55,230,000 0.71% 230,200 $257.12
10 2021 - Q3 (2021-09-30) $66,276,000 0.72% 234,200 $327.75
11 2021 - Q2 (2021-06-30) $23,339,000 0.23% 67,400 $302.94
12 2021 - Q1 (2021-03-31) $22,940,000 0.21% 82,000 $269.69
13 2020 - Q4 (2020-12-31) $129,629,000 1.13% 529,400 $259.08
14 2020 - Q3 (2020-09-30) $203,087,000 2.55% 715,900 $278.91
15 2020 - Q2 (2020-06-30) $191,539,000 2.69% 715,900 $300.59
16 2020 - Q1 (2020-03-31) $151,989,000 2.55% 480,400 $303.47
17 2019 - Q4 (2019-12-31) $19,139,000 0.27% 64,500 $277.46
18 2019 - Q3 (2019-09-30) $8,428,000 0.15% 36,200 $232.85
19 2019 - Q2 (2019-06-30) $20,510,000 0.31% 87,700 $230.90
20 2019 - Q1 (2019-03-31) $20,731,000 0.32% 87,700 $314.89
21 2018 - Q4 (2018-12-31) $251,343,000 4.64% 835,249 $319.14
22 2018 - Q3 (2018-09-30) $321,618,000 3.87% 910,300 $344.30
23 2018 - Q2 (2018-06-30) $338,971,000 4.04% 1,167,900 $281.15
24 2018 - Q1 (2018-03-31) $284,882,000 3.53% 1,040,400 $310.41
25 2017 - Q4 (2017-12-31) $392,064,000 4.95% 1,230,700 $320.80
26 2017 - Q3 (2017-09-30) $510,386,000 4.87% 1,630,000 $296.11
27 2017 - Q2 (2017-06-30) $442,317,000 4.63% 1,630,000 $264.42
28 2017 - Q1 (2017-03-31) $392,877,000 4.45% 1,436,900 $282.75
29 2016 - Q4 (2016-12-31) $363,323,000 4.62% 1,281,200 $296.43
30 2016 - Q3 (2016-09-30) $417,551,000 4.75% 1,333,900 $296.18
31 2016 - Q2 (2016-06-30) $362,827,000 3.78% 1,500,400 $263.54
32 2016 - Q1 (2016-03-31) $397,326,000 4.18% 1,526,300 $264.15
33 2015 - Q4 (2015-12-31) $441,910,000 4% 1,442,500 $287.35
34 2015 - Q3 (2015-09-30) $381,512,000 3.85% 1,307,400 $330.23
35 2015 - Q2 (2015-06-30) $516,599,000 4.31% 1,278,900 $401.33
36 2015 - Q1 (2015-03-31) $509,559,000 4.34% 1,206,800 $394.14
37 2014 - Q4 (2014-12-31) $507,376,000 4.84% 1,494,700 $323.51
38 2014 - Q3 (2014-09-30) $393,697,000 4.11% 1,190,100 $329.72
39 2014 - Q2 (2014-06-30) $341,859,000 4.01% 1,084,200 $300.97
40 2014 - Q1 (2014-03-31) $324,436,000 3.98% 1,060,700 $317.43
41 2013 - Q4 (2013-12-31) $306,159,000 4.49% 1,095,100 $258.65
42 2013 - Q3 (2013-09-30) $247,116,000 4.4% 1,026,400 $223.81
43 2013 - Q2 (2013-06-30) $220,752,000 4.67% 1,025,800 $213.68
44 2013 - Q1 (2013-03-31) $136,720,000 3.17% 709,800 $161.63
45 2012 - Q4 (2012-12-31) $115,676,000 3.56% 790,300 $147.07
46 2012 - Q3 (2012-09-30) $117,891,000 3.38% 790,100 $147.13
47 2012 - Q1 (2012-03-31) $92,534,000 2.74% 734,400 $118.81
48 2011 - Q4 (2011-12-31) $54,893,000 1.8% 498,800 $109.04
49 2011 - Q3 (2011-09-30) $17,633,000 0.65% 189,300 $97.12
50 2011 - Q2 (2011-06-30) $19,887,000 0.36% 186,000 $93.03
51 2011 - Q1 (2011-03-31) $13,210,000 0.44% 179,800 $68.26
52 2010 - Q4 (2010-12-31) $19,491,000 0.7% 290,700 $63.25

The displayed share prices are average quarterly stock market prices.